Turtle Pharma
Mumbai, India· Est.
Indian GMP‑certified API manufacturer delivering customized small‑molecule ingredients for global pharma clients.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian GMP‑certified API manufacturer delivering customized small‑molecule ingredients for global pharma clients.
Anti‑inflammatoryOphthalmologyDiabetesInfectious DiseasesCardiovascularHypertensionNeurology
Technology Platform
A flexible cGMP‑compliant small‑molecule synthesis platform capable of diverse reactions (chlorination, bromination, cyclisation, etc.) and scale‑up from gram to kilogram batches, with custom particle‑size, solubility, and sterile packaging options.
Opportunities
Rising global demand for high‑quality generic APIs and specialty intermediates, combined with Turtle Pharma’s SEZ location and broad reaction capability, offers strong export growth potential.
Risk Factors
Regulatory compliance challenges, intense price competition from larger Indian API manufacturers, and exposure to patent litigation in key markets.
Competitive Landscape
Competes with established Indian API firms such as Sun Pharma, Aurobindo, and Lupin; differentiation rests on flexible small‑scale pilot production, extensive reaction portfolio, and multiple quality certifications.